Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Neoplasms by Site × Surgical Procedures, Operative × Clear all

Sponsor

Conditions

Breast Neoplasms 18 Carcinoma, Non-Small-Cell Lung 11 Rectal Neoplasms 9 Esophageal Neoplasms 8 Stomach Neoplasms 7 Glioblastoma 7 Squamous Cell Carcinoma of Head and Neck 6 Pancreatic Neoplasms 5 Lung Neoplasms 5 Head and Neck Neoplasms 5 Colorectal Neoplasms 5 Ovarian Neoplasms 4 Fallopian Tube Neoplasms 4 Sarcoma 3 Colonic Neoplasms 3 Brain Neoplasms 3 Adenocarcinoma of Lung 3 Urinary Bladder Neoplasms 2 Osteosarcoma 2 Neoplasms 2 Melanoma 2 Glioma 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Intraductal, Noninfiltrating 2 Adenocarcinoma Of Esophagus 2 Xerostomia 1 Wilms Tumor 1 Urethral Neoplasms 1 Triple Negative Breast Neoplasms 1 Testicular Neoplasms 1

Interventions

Gemcitabine 4 130-nm albumin-bound paclitaxel 4 pembrolizumab 3 napabucasin 3 Paclitaxel 3 Irinotecan 3 pralsetinib 2 patritumab 2 Standard of Care 2 Pemetrexed 2 Cyclophosphamide 2 Cisplatin 2 Carboplatin 2 Ascorbic Acid 2 Albumin-Bound Paclitaxel 2 valrubicin 1 sotorasib 1 selpercatinib 1 ribociclib 1 relatlimab 1 pamiparib 1 osimertinib 1 ipatasertib 1 durvalumab 1 dostarlimab 1 cobimetinib 1 atezolizumab 1 alectinib 1 Tyrosine Kinase Inhibitors 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡